AR and prostate carcinoma: In this process, LINC00844 promotes the expression of N-myc downstream regulatory gene 1 (NDRG1), and NDRG1 acts as an AR repressor to inhibit AR expression, and the metastasis and differentiation of prostate cancer cells are also inhibited after the AR signaling pathway is suppressed.